Rotator cuff tears are common soft tissue injuries of the musculoskeletal system that heal by formation of repair tissue and may lead to high retear rates and joint dysfunction. In particular, tissue from chronic, large tendon tears is of such degenerative nature that it may be prone to retear after surgical repair. Besides several biomechanical approaches, biologically based strategies such as application of growth factors may be promising for increasing cell activity and production of extracellular tendon matrix at the tendon-to-bone unit. As a precondition for subsequent experimental growth factor application, the aim of the present study was to establish and characterize a human rotator cuff tendon cell culture.
Introduction
Rotator cuff tendon injuries cause pain and disability. Although surgical approaches may provide good and excellent results in many patients (Severud et al., 2003; Wolf et al., 2004; Baysal et al., 2005) , the main complication remains non-healing or retear of the tendon from its humeral footprint. Retears occur in up to 94% of cases and depend on several variable issues such as demographic factors, size of the initial tear, biologic characteristics (fatty infiltration, tendon tissue quality) and biomechanical aspects of the chosen surgical technique (Boileau et al., 2005; Bishop et al., 2006; Cole et al., 2007) The natural history of retears or recurrent defects remains unknown. The therapeutic aim of rotator cuff surgery represents a secure and durable tendon-to-bone regeneration.
To improve outcome results, biomechanical approaches for new surgical techniques have led to increased use of strong synthetic materials in order to reattach the torn tendon stump (Mahar et al., 2007; Lorbach et al., 2008; Pauly et al., 2010) . However, the assumption of tissue damage and tendon strangulation through strong tissue adaption to the bony insertion is possible and might even deteriorate regeneration (Gerber et al., 1994; Flatow, 1996) .
Biologically based strategies to stimulate cell activity and production of extracellular tendon matrix proteins have received increasing attention (Maffulli et al., 2002; Hsu and Chang, 2004) . Since tenocytes exhibit very low proliferative capacity (Chuen et al., 2004) , one possible approach for improved tendon healing is to assess their biological activity under the influence of growth factors. The latter are considered to accelerate ligament and tendon-to-bone healing (Molloy et al., 2003; Hsu and Chang, 2004; Angel et al., 2006) by increasing fibroblast proliferation, the synthesis of extracellular matrix (ECM) proteins, and revascularization (Lee et al., 1995; Batten et al., 1996; Marui et al., 1997; Thomopoulos et al., 2007; Chang et al., 2000; Takahasih et al., 2002) .
Tendon cell cultures represent a precondition for studies on their biology and influence of growth factors. Hence, numerous studies have been carried out on tendon cell cultures from tissue samples of human or animal origin that were subsequently studied. However, many studies lack a specific characterization of the obtained cell cultures. Reviewing the current literature, the presence of tenocytes was assumed by phenotypic criteria or proof of collagen type-I (COL-I) (Thomopoulos et al., 2005; Costa et al., 2006; Anitua et al., 2006; which cannot be considered tendon specific. Other studies furthermore assessed COL-III (Maffulli et al., Takahasih et al., 2002; Yang et al., 2004; de Mos et al., 2008) or proteins such as decorin and biglycan (Kardestuncer et al., 2006; Yao et al., 2006; Rios et al., 2007; Fu et al., 2008) which are non-specific tendon proteoglycans (Rees et al., 2000; Yoon and Halper, 2005) and are initially increased after experimental tendon detachment (in rodents) (Yokota et al., 2005) . The possibly tendon specific gene Scleraxis (Schweitzer et al., 2001; Edom-Vovard et al., 2002) was described for characterization of cells isolated from human or rodent tendon (Salingcarnboriboon et al., 2003; SchulzeTanzil et al., 2004) . Only few studies looked into characterization more detailed and described the expression of several markers such as COL-I, -III, decorin, COMP, aggrecan, elastin and scleraxis (Stoll et al., 2010) or COL-I, -II, scleraxis, fibronectin, proteoglycan and β1-integrin (Schulze-Tanzil et al., 2004) .
CHARACTERIZATION OF TENDON CELL CULTURES OF THE HUMAN ROTATOR CUFF
In the present approach, cells were isolated from human rotator cuff tissue samples, cultivated and subsequently screened for several markers. These markers were COL-I (main component of extracellular tendon matrix (Blevins et al., 1997; Kannus, 2000) ), COL-III (increased in early tendon healing (Takahasih et al., 2002) and experimentally in chronic tears (Yokota et al., 2005) ), decorin (most important proteoglycan in tendon (Rahaman and Mao, 2005; Yoon and Halper, 2005) ) and biglycan (a proteoglycan present in tendon, cartilage and bone (Yoon and Halper, 2005) ), aggrecan (a proteoglycan, present in cartilage as well as in compressed tendon regions (Rees et al., 2000) , and tenascin C (a glycoprotein, part of tendon cell adaptation to compression (Martin et al., 2003) ).
Cultures were furthermore screened for scleraxis (a transcription factor and possibly a tendon specific marker (Schweitzer et al., 2001) ), tenomodulin (a transmembrane glycoprotein, possibly another tendon-specific marker (Jelinsky et al., 2010) ), COL-II (cartilage specific) and osteocalcin (the major non-collagen protein in the bone matrix, bone-specific), to separate the tenocyte-like cells from other cell types of the musculoskeletal tissues.
The aim of the present study was to establish and characterize a human rotator cuff tenocyte-like cell culture in order to allow subsequent systematic studies on their biological response to growth factors.
Materials and Methods
Tendon material, donor patient demographics Tendon samples were obtained from patients undergoing arthroscopic surgery for rotator cuff repair or open shoulder surgery such as hemiarthroplasty following humeral head fractures. Prior to biopsy, all patients gave their written informed consent. Tissue samples from the supraspinatus muscle (SSP, n=11) and the tendon of the long head of the biceps muscle (LHB, intraarticular aspect, n=7) were obtained.
Patient demographics and clinical data
SSP tenocyte-like cells (n=11 samples: 8 male, 3 female, mean age 63.7 yrs, range 32-85yrs):
-Tendon retraction according to Patte: grade 0-3 (Patte, 1990) -Fatty infiltration of the SSP muscle: grade I-III according to Goutallier (Goutallier et al., 1994) -Tear size according to Bateman: stage I-IV (Bayne and Bateman, 1984) . LHB tenocyte-like cells (n=7 samples: 5 male, 2 female, mean age 59.3yrs, range 23-79 yrs).
Exclusion criteria for LHB-samples were macroscopic evidence of chronic inflammation/tendinitis. LHB-samples were obtained during hemiarthroplasty or tenotomy/ tenodesis following a failed SLAP-repair. 2 LHB-biopsies were obtained during repair/-debridement of concomitant (massive) rotator cuff and pulley-defects.
All biopsies were obtained 3-5 mm from the torn proximal tendon edge.
Tendon cell cultures:
Cells were isolated from tissue samples by washing several times with phosphate buffered saline (PBS) +1% penicillin/ streptomycin, dissection into small pieces and incubation with 0.3% collagenase type CLS II in PBS with Ca/Mg for 2 hours at 37°C. The digested tendon material was then placed in a tissue culture flask and cultured in DMEM / HAM's F12 (1:1) supplemented with 10% foetal calf serum (FCS) and 1% penicillin/streptomycin.
Cells were incubated at 37°C, 95% humidity and 5% carbon dioxide with a change of medium every 2-3 days. As soon as cultured cells reached 80-90% confluence, they were treated with 0.05% trypsin/0.02% ethylenediaminetetraaciticacid (EDTA) and subcultured at a density of 1-1.5x10 4 cells/ml, maximum until passage 3 (about 8 weeks).
Chondrocyte and osteoblast cultures
Primary human chondrocytes (n=3) and osteoblasts (n=3) served as control for marker expression and immunocytochemical staining. All patients gave their written informed consent prior to cell culture.
Primary human chondrocyte cultures were kindly provided by Dr. Ringe, Department of Tissue Engineering, Berlin-Brandenburg Centre for Regenerative Therapies. Chondrocytes were cultured in DMEM / HAM's F12 (1:1) supplemented with 10% FCS and 1% penicillin/ streptomycin under the same conditions as described above. Chondrocytes were used for experiments at early passages (up to passage 2) to avoid dedifferentiation.
Primary human osteoblasts were isolated as described previously (Robey and Termine, 1985) . The osteoblasts were cultured in MEM EARLE / HAM's F12 supplemented with 10% FCS, 1% penicillin/streptomycin, 0.05 mM β-glycerophosphate and 0.05 mM L-ascorbate-2-Phosphate under the same conditions as described for tenocytes. Osteoblasts were used up to passage 4.
All cell culture media and supplements were obtained from Biochrom AG, Berlin, Germany.
Real-time Polymerase Chain Reaction (RT-PCR)
RNA from about 1-2x10 5 cells of the tenocyte-like cells, chondrocytes and osteoblasts was extracted with the S Pauly et al.
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RNeasy Mini Kit (Quiagen, Hilden, Germany) following the manufacturer's manual and then reverse transcribed into cDNA. RNA concentration was measured with the Nanodrop ND-1000 Spectrophotometer (PeqLab, Erlangen, Germany). A thermocycler (Eppendorf, Hamburg, Germany) was used for cDNA synthesis. 100 ng of RNA, 1 μL 10 mM Deoxynucleotidetriphosphate (dNTP)-mix (Invitrogen, Darmstadt, Germany) and 1 μL Randomprimer (Invitrogen) were filled up to 10 μL with aqua ad iniectabilia (Braun, Germany) and incubated for 5 minutes at 65°C. After incubation on ice 9.5 μL reaction-mix consisting of 4 μL M-MLV RT 5x Reactionbuffer (Promega, Mannheim, Germany), 1 μL RNase-inhibitor (40 U/μL, Promega) und 4.5 μL aqua ad iniectabilia were added and incubated for 2 minutes at 42°C. 1 μL M-MVL RT(H-) (200 U/μL, Promega) was added and incubated for 50 minutes at 42°C, then samples were cooled down and 1 μL RNase H (1.5 U/μL, Promega) was added and incubated for 20 minutes at 37°C.
The following primers were used for RT-PCR: GAPDH (housekeeping gene, serving as reference), aggrecan, biglycan, COL-I, -II, -III, decorin, osteocalcin, scleraxis, tenascin C, tenomodulin. Most primer sequences were designed using the Primer 3 software, some sequences were adapted from other publications ( Table 1 ). All primers, except Scleraxis, were produced by Tib Molbiol, Berlin, Germany.
The RT-PCR was performed with the iCycler iQ5 RT-PCR System and the Bio-Rad iQ5 software (Bio-Rad Laboratories, Munich, Germany). The cDNA was diluted 1:10 and 2 μL were pipetted at each well as PCR Template. The mastermix was prepared with the following components for one well: 12.5 μL iQSupermix (Bio-Rad), 1 μL primermix (10 μM, forward and reverse Primer 1:1), 1 μL SYBR Green (Invitrogen) and 8.5 μL aqua ad iniectabilia. 23 μL of the mastermix were added to each well. The following RT-PCR protocol was used for the amplification: denaturation program (95°C for 3 minutes) amplification program was repeated for 40 cycles (94°C for 30 s, 59.9°C/64.2°C/66°C for 30 s, 72°C for 30 s), melting curve program (55-95°C with a temperature change of 0.5°C holding for 30 s) and finally a cooling step at 15°C. The RT-PCR results were analysed with the Bio-Rad iQ5 Software by calculating the ratio of target gene versus GAPDH gene.
Immuncytochemical Scleraxis staining
The tenocyte-like cells, chondrocytes and osteoblasts were seeded into 4-well chamber slides with a concentration of 2x10 4 vital cells/ml (1 mL/well), until they reached 80% confluence. The cells were fixed for 5 minutes at room temperature in 3.7% formaldehyde in PBS. The cells were permeabilized using 1% Triton-X-100 in PBS for 15 minutes at room temperature. After incubation with normal goat serum (Vector Labs, Loerrach, Germany), the cells were stained with primary antibodies for Scleraxis (rabbit polyclonal anti SCXA, 4 μg/mL, Abcam, Cambridge, MA, USA) overnight at 4°C. Negative control was prepared by omitting the primary antibody. The cells were washed with PBS and the biotinylated anti-rabbit IgG antibody was used and subsequently incubated with the Vectastain ABC AP Kit (Vector Labs) for 50 minutes. Cells were then incubated with chromogen buffer (pH 8.2) for 10 minutes. The Vector Red Alkaline Phosphatase Substrate Kit (Vector Labs) was used and the reaction developed under visual control. The reaction was stopped with PBS and few drops 
Results

Cell culture
Tenocyte-like cells proliferated to 80-90% confluence approximately within 14 days. The isolated cells exhibited a spindle shape and particularly built reticular colonies in cell chains (Fig. 1a, b) . After subculture, the cells lost this appearance. Partially they became larger and built winglike shapes (Fig. 1c, d ).
RT-PCR Analysis of different markers by RT-PCR demonstrated
an obvious dissociation of tenocyte-like cells from chondrocytes and osteoblasts. In general, data suggest that tenocyte-like cells from either SSP or LHB origin have comparable expression patterns for all analysed markers. COL-I and -III gene expression showed differences in tenocyte-like cells from SSP and LHB tendon compared to chondrocytes and osteoblasts.
The tenocyte-like cells isolated from the SSP and LHB tendons expressed COL-I in a comparable amount. The osteoblasts showed the highest COL-I expression compared to the other cell types. A very low COL-I expression was found for the chondrocytes, which was significantly below SSP (p=0.016) and LHB (p=0.017) tenocyte-like cells and osteoblasts (p=0.05) (Fig. 2a) .
COL-III expression was detected in all investigated cell types and was highest in osteoblasts. However, expression was not differing significantly (Fig. 2b) .
Proteoglycans and glycoproteins
A slight increase of decorin expression was observed for chondrocytes when compared to tenocyte-like cells and Human rotator cuff tendon cell cultures to osteoblasts. Expression of decorin was similar between tenocyte-like cells and osteoblasts (Fig. 3a) . The expression of biglycan was comparable between chondrocytes and tenocyte-like cells. A marginal increase of its expression was found for osteoblasts (Fig. 3b) . The difference was significant compared to SSP tenocyte-like cells after Mann-Whitney-U-Testing (p=0.036) but not when adjusted by Bonferroni-Holm-Correction.
Expression of aggrecan was slightly elevated in chondrocytes compared to tenocyte-like cells from LHB and SSP tendon as well as to osteoblasts (p>0.05 each, Fig. 3c ).
Osteoblasts showed higher expression of tenascin C compared to tenocyte-like cells and to chondrocytes (p>0.05 each, Fig. 3d ).
Cartilage, bone and tendon markers
A very low level of COL-II expression was measured for tenocyte-like cells and osteoblasts. Its expression in chondrocytes was significantly higher compared to the other cell types (SSP: p=0.01; LHB: p=0.014; osteoblasts: p=0.046, Fig. 4a )
Regarding bone markers, osteocalcin showed significantly higher expression in osteoblasts when compared to SSP tenocyte-like cells (p=0.009), LHB tenocyte-like cells (p=0.017) and chondrocytes (p=0.05) (Fig. 4b) .
Scleraxis expression was low in all three cell types and no significant differences were observed (Fig. 4c) .
Expression of tenomodulin was very low and almost similar in all cell types without significant differences (Fig.  4d) .
In summary, both SSP and LHB tenocyte-like cells differed from chondrocyte cell cultures in terms of significantly reduced expression of COL-II and lower decorin expression while significantly higher COL-I-levels were seen.
With respect to osteoblasts, tenocyte-like cells expressed significantly lower levels of osteocalcin as well as reduced tenascin C, biglycan and collagen type-III.
Immunocytochemical scleraxis staining
In order to confirm RT-PCR results for the possible tendon specific marker scleraxis, SSP tenocyte-like cells, chondrocytes and osteoblasts were immunocytochemically stained for scleraxis. The staining showed high positive findings in all cell types. No visible distinctions in intensity between the cell types could be detected (Fig. 5 a-c) . For the negative control cells, no staining could be detected (Fig. 5b , data of negative osteoblast and chondrocyte control not shown).
Discussion
Following surgical rotator cuff repairs, retear or nonhealing of the tendon is a relevant clinical problem (Boileau et al., 2005; Cole et al., 2007; Lafosse et al., 2007) . Besides biomechanical improvements (Lorbach et al., 2008; Mahar et al., 2007; Pauly et al., 2010) , recent approaches have suggested an influence of growth factors on tendon cell behaviour and their potential value in rotator cuff repair.
Numerous studies on cell cultures from human tendon tissue were carried out ( Table 2) . Few of these surveys focus on cells from human rotator cuff tissue (Gumina et al., 2009; Takahasih et al., 2002; Tempfer et al., 2009) . However, many of these studies lack characterizations that allow the specific assumption of tendon cells. In particular, phenotypic assessment or proof of different collagen-types (Gumina et al., 2009; Li et al., 2008; Maffulli et al., 2000; Takahasih et al., 2002; Yang et al., 2004) are not precise enough as these are expressed in various fibroblastdependent conjunctive tissues. A similar situation is the Human rotator cuff tendon cell cultures examination of growth factors expressed in vitro (Anitua et al., 2006; De Mos et al., 2008) , Matrix metalloproteinases (MMP) (Tempfer et al., 2009) or surface clusters of differentiation (Scutt et al., 2008) which are not specific for tendon tissue. Other authors assessed the presence of possibly tendon specific gene markers (Schulze-Tanzil et al., 2004) or non specific proteoglycans (Kardestuncer et al., 2006) while characterization of tendon cells obtained for further experiments was not described in some studies Wang et al., 2008) . A characterization of the cultured cells therefore seems mandatory as a precondition for subsequent investigations of their biology. The aim of the present study was to characterize tenocyte-like cells from the human rotator cuff as precisely as possible using a spectrum of tendon markers on geneand protein-base. Furthermore, tenocyte-like cells were compared to other cell types of the musculoskeletal system such as osteoblasts and chondrocytes. The majority of cells within healthy tendon tissue cells are tenocytes besides small amounts of chondrocytes (Kannus, 2000) . Moderate COL-II expression is observed in vivo in human rotator cuff tendon (Gigante et al., 2004; Martin et al., 2003) and was presently confirmed for cultivated rotator cuff tendon cells.
Increased amounts of chondrocytes can be present in overused tendon (Archambault et al., 2007) or chronic rotator cuff tears: In vivo transdifferentiation was observed in larger rotator cuff tears, especially in tendon stump areas of low fibroblast presence (Fukuda et al., 1990 ; Matthews , 2006) . Other authors suggested that chondroid metaplasia may be influenced by both compression and tension forces in human rotator cuff prior to complete tear (Gigante et al., 2004) . Furthermore, tendon cells isolated from their natural biomechanical surrounding may transdifferentiate into fibrocartilage cell lines in vitro (Ehlers and Vogel, 1998; Jelinsky et al., 2010; SchulzeTanzil et al., 2004) . Present tenocyte-like cells differed from chondrocytes in terms of reduced expression of COL-II while higher COL-I-levels were found. COL-I is the main component of extracellular tendon matrix (Blevins et al., 1997; Kannus, 2000) . Its synthesis is increased initially after rotator cuff tendon injury and then decreased with time in chronic tears (Yokota et al., 2005) . Tenocyte-like cells presently expressed COL-I. Hence, COL-I cannot be considered tendon specific. Tenocyte-like cells furthermore showed significant differences from osteoblasts in terms of osteocalcin expression, a bone-specific non-collagen protein in the bone matrix.
Cultivation of small amounts of chondrocytes or osteoblasts cannot be ruled out by the present approach. However, tenocyte-like cells in total showed expression patterns significantly different from chondrocyte and osteoblast cultures with regard to characteristic markers. Besides significant differences to other musculoskeletal cell types, several other markers were investigated. Even though these cannot be considered specific, however, their respective presence in tendon was described and hence should be confirmed in vitro. Human rotator cuff tendon cell cultures COL-III was expressed by the tenocyte-like cells with a slight decrease compared to osteoblasts. As another component of ECM (Kannus, 2000) , COL-III production is increased in tenocytes from ruptured and tendinopathiccompared to intact Achilles tendon (Maffulli et al., 2000) . In the present study, tendon material was obtained from torn rotator cuff and expression of COL-III was not compared to intact rotator cuff biopsies to potentially confirm this observation.
The expression profile of COL-III over time during tendon healing was described (Hefti and Stoll, 1995; Takahasih et al., 2002; Yokota et al., 2005) , but present amount of COL-III expression does not allow approximation of the time point of rotator cuff tear.
Decorin and biglycan are non-specific proteoglycans in several tissue types such as tendon, cartilage and bone (Rees et al., 2000; Yoon and Halper, 2005) . Both were increased initially after experimental tendon detachment (chronic tear model) and then decreased, although Decorin remained elevated from normal for months after injury (Yokota et al., 2005) . In the present cell culture study, decorin was expressed lower in both SSP and LHB tenocyte-like cells when compared to chondrocytes. Biglycan was expressed in a comparable quantity for both chondrocytes and tenocyte-like cells while osteoblasts expressed slightly more biglycan. Both markers were detected in the tenocyte-like cells as expected but do not exclusively allow the characterization of tenocyte-like cells.
As a proteoglycan present in fibrocartilage and tendon (Rees et al., 2000; Yoon and Halper, 2005) , aggrecan was expressed by both tenocyte-like cell types while slightly higher amounts were seen in chondrocytes. High levels are expressed in compressed regions of tendon and particularly in fibrocartilage, while low levels are expressed in tensional parts (Yoon and Halper, 2005) . In vivo, both SSP and LHB tendons are subjected to both traction-and compression forces depending on the position of the humeral head. Osteoblasts expressed aggrecan as described before (Wong et al., 1992) .
Tenascin-C is an anti-adhesive ECM protein and present in musculoskeletal regions that are transmitting mechanical forces from one tissue component to another (Jarvinen et al., 2000) , such as osteotendinous junctions as well as articular cartilage (Kannus et al., 1998) . Isoforms of tenascin-C in degenerated tendon were suggested to potentially stimulate tenocyte proliferation (Riley et al., 1996) . The expression of tenascin-C is regulated by mechanical stress (Chiquet-Ehrismann and Tucker, 2004) and is elevated in degenerative SSP tendon (Riley et al., Human rotator cuff tendon cell cultures 1996). Compared to tenocyte-like cell cultures, slightly elevated expression of tenascin C was found in chondrocyte and osteoblast controls. Several approaches to establish effective primers for scleraxis were unsuccessful: no products were obtained or non-desired dimers were formed, respectively. The targeted Scleraxis-gene is rather short compared to other gene-sequences (with only about 2600 bases) and has just two exons which reduces the chance of designing a reliable primer. Using a commercially available primer, comparable amounts of scleraxis were obtained for tenocyte-like cells, chondrocytes and osteoblasts in both RT-PCR and in immunocytochemical staining. These findings might suggest that scleraxis is non-specific for tendon which was supported by its detection in several other musculoskeletal tissues (Edom-Vovard et al., 2002; Jelinsky et al., 2010) . In contrast, other authors reported on Scleraxis as a tendonspecific gene (Schweitzer et al., 2001) which regulates the expression of tenomodulin (Shukunami et al., 2006) . Significant differences in scleraxis expression were reported between human chondrocyte and flexor tendon cells of one adult donor. However, a 3D-culture was used which potentially may explain different expression patterns (Schulze-Tanzil et al., 2004) . Jelinsky et al., 2010) human tendon tissue COL-I, -III, decorin, COMP, aggrecan, elastin, scleraxis, Sox9 (Stoll et al., 2010) human hamstring tendon COL-I, -III, decorin (Yao et al., 2006) human achilles tendon COL-I, -III, fibronectin, MMP-12, TIMP-1 (Almarza et al., 2008) Human medial collateral ligament (MCL), ACL, patellar tendon www.ecmjournal.org
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Tenomodulin is a transmembrane glycoprotein which is non-specific, but mainly expressed in tendon and ligament (Shukunami et al., 2006) . Other authors claimed tenomodulin as a selective tendon gene (Jelinsky et al., 2010) . Its high expression compared to different other tissues, however, is fading when cells are cultured twodimensionally (Jelinsky et al., 2010) . The tenocyte-like cells in the present study were cultured in monolayers, which may explain its low expression. Furthermore, moderate expression of tenomodulin was reported in cartilage and bone (Jelinsky et al., 2010) , which is in accordance with the present low expression in chondrocytes and osteoblasts.
Brune et al. analyzed tendon cells from intact vs. torn ligament and observed differences in expression patterns but similar behaviour when seeded for tissue engineering (Brune et al., 2007) . Other authors suggested fibroblast cultures from healing instead of intact tendon to be more appropriate for studying cellular tendon regeneration (Fu et al., 2008) . In contrast to other authors focusing on intact human rotator cuff material (Tempfer et al., 2009) , donor material for the present study was obtained from torn rotator cuff. This cannot be classified as healing but was submitted to structural and biomechanical changes prior to biopsy.
Indeed, intact tendon tissue may not reflect the biological situation in chronic rotator cuff tears as assessed during surgical reconstruction. The present analysis of torn human rotator cuff tissue was in accordance with expression profiles in rodent experiments on chronic cuff tear models (Yokota et al., 2005) .
Study limitations
As a limitation of the present study, no possible correlations of the investigated tenocyte-like cell culture characteristics with respective patient subgroups were investigated. A prospective study in a rather small series of cases was performed to generally analyze whether or not a human rotator cuff cell culture can be established. As a further weakness, neither 3D-cell cultures nor biomechanical stimulation of obtained cell cultures were investigated. We hypothesize that tenocyte-like cells grown under different culture conditions on scaffolds could show a variable phenotype compared to monolayer culture as shown by other publications (Theisen et al., 2010; Stoll et al., 2010) .
Conclusions
The present study describes the successful cultivation of human rotator cuff cells. Characterization of these rotator cuff cells showed an expression pattern of different gene markers that is unique for these cell types and in parts significantly different to osteoblasts and chondrocytes.
As a conclusion of our results it seems to be important to look at the collective expression profile of the tenocytelike cells. COL-I is the most important protein for tenocytelike cells and should be highly expressed. COL-III, biglycan, decorin, and tenascin C should also be expressed while COL-II and osteocalcin expression should be present just in low amounts.
Since no specific gene-or protein markers for tendon are known so far, the present approach represents a description as close as possible based on currently discussed markers. This characterization is necessary for further studies on the biology and stimulation of tendon cells in order to optimize therapy outcome in rotator cuff cells. et al., 2002) or DMEM/HAM's F12 (Tsai et al., 2003) medium without supplements such as ascorbate. We followed the decision to culture the cells this way and did not observe any problems with cell viability or activity.
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Reviewer II: I am also unconvinced by the scleraxis labels; as indicated above I think an extra control is necessary, along with some positive controls. It seems odd that all cells should stain with a very low level of expression as measured by supposedly high sensitivity qPCR methodology should label, along with cell types that are not generally associated with expression of this molecule. Authors: Two different methods to analyse the scleraxis expression and production were performed. By quantitative RT-PCR we found low levels of scleraxis. Using this quantitative method we did not expect high levels of this transcription factor as seen for all matrix proteins in this study. In contrast to RT-PCR, immunocytochemistry is no quantitative method and can only visualize whether or not a protein is present. Therefore, we suggest that the unequal results are not caused by wrong protocols but are normal variances obtained from methods that are different in principle.
Reviewer II: There is no doubt that you have cultured cells from the rotator cuff tendon that are different from chondrocytes and osteoblasts, but it is difficult to draw conclusions as to their behaviour in culture as they seem to be doing very little. Perhaps supplementation with ascorbate, as you do for osteoblasts, might helposteoblasts seem to be the most active cells in your experiments. It is very difficult to make comparisons between these cell types given the differences in culture medium supplements. Authors: We agree that differences in cell culture supplements like ascorbate could influence the matrix expression. But no comparative study on tenocytes was found to prove this. Ibold et al. showed the influence of S Pauly et al.
Human rotator cuff tendon cell cultures different ascorbate supplementations on chondrocyte pellet cultures. 100 μM L-ascorbate-2-phosphate (we used 50 μM) resulted in decreased COL-I expression at the beginning of the culture and slightly increased COL-II and aggrecan expression (Ibold et al., 2009) . Another study on mesenchymal stem cells revealed that ascorbate supplementation (0-500 μM) had almost no effect on growth and proliferation until passage 3 (Choi et al., 2008) . Son et al. demonstrated that ascorbate supplementation (60 and 125 μM) did not affect the collagen expression (Son et al., 2007) . To rule out an effect of the different culture conditions on matrix expression, we agree that it would have been better to culture all cells with the same supplementations. But with respect to the mentioned studies we would not expect a marked difference in expression profiles. We therefore think that our comparison is reasonable.
